Our Story
to cutting-edge animal laboratories, Kolmar BioTech
delivers tailored solutions to accelerate drug development.
With comprehensive infection control services — including facility design,
engineering & construction, lab equipment, and maintenance — we are
committed to minimizing infection risks, promoting health and well-being future.
CEO Message
Kolmar BioTech: Trusted Partner for New Drug Development
At the core of this advancement is open innovation—active collaboration, shared expertise, and a strong network are essential. This vision led to the creation of the kolmar BioCluster for New Drug Development. It is a leading innovation hub, offering a one-stop platform for R&D. Through this, we foster South Korea's drug development ecosystem with the vision to grow into a global hub.
Our Cluster offers world-class infrastructure to support every phase of preclinical research: from cutting-edge animal lab center to high-precision efficacy evaluation centers and pharmaceutical analysis centers. Through LAB CLOUD, we also empower biotech startups with shared labs, office spaces, and acceleration programs, enabling them to solely focus on their research.
Since our founding in 1989, Kolmar BioTech has been a trusted partner for innovators, providing the infrastructure and expertise needed to turn ideas into therapies.
At Kolmar BioTech, we believe that "Success lies in open innovation," and we look forward to advancing the future of healthcare with you.
Sincerely,
Byoung Seok Moon
Kolmar BioTech CEO Byoung Seok Moon
HISTORY
History of Kolmar BioTech: Built Together with our clients
2026
scroll down
-
2026
-
07
Company name changed to Kolmar BioTech
-
04
Byung-seok Moon appointed CEO
-
2025
-
06
Reacquired Full AAALAC Accreditation
-
2024
-
07
Patent Registered for Hydrogen Peroxide Vaporization and Decomposition System
-
2023
-
06
Highest Sales Award (TECNIPLAST)
-
05
Selected as a TIPS (Tech Incubating Program for Startups) operator
-
2022
-
03
Korea Excellent Laboratory Animal Facility(KELAF) Designation (Headquarters)
-
02
Full AAALAC Accreditation
-
2021
-
10
Hosted 1st WOOJUNG BIO Cluster Symposium
-
09
Completed construction of the WOOJUNG BIO Cluster for New Drug Development
-
2020
-
08
INNOBIZ certification
KELAF designation (Gwanggyo branch)
-
04
Inauguration of Chairman Lee Jong-wook
-
2018
-
08
Groundbreaking ceremony for the WOOJUNG BIO New Drug Cluster
-
04
Selected as a Strong Small Business by the Ministry of Employment and Labor
-
2017
-
04
Listed on KOSDAQ
-
2016
-
08
Signed technology transfer and agreement with the Korea Institute of Science and Technology
-
05
GLP research facility certification
-
04
Certified as a Youth-Friendly Business by the Ministry of Employment and Labor
-
2015
-
12
Award for LMO Research Facility (by the President of the Korea Research Institute of Bioscience and Biotechnology)
-
2014
-
11
Selected as a Technologically Advanced Small Business by the Gyeonggi Provincial Small and Medium Business Administration
-
07
Hosted the 25th Anniversary International Conference on Animal Laboratory Modernization and Innovative Solutions
-
2013
-
06
ISO 9001, 14001 certifications
-
2012
-
09
Selected as an Excellent SME in Gyeonggi Province
-
03
Designated as a venture company
-
2010
-
06
Establishment and certification of WOOJUNG BIO Life Science Research Institute
-
04
Registration as a biological product manufacturing plant
-
2008
-
04
Relocated to the Next-Generation Convergence Technology Institute
-
1989
-
04
Established WOOJUNG BIO